Aethlon Medical, Inc. (AEMD) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated November 13, 2024, serves as a current report for Aethlon Medical, Inc., a Nevada corporation headquartered in San Diego, California. The filing primarily addresses the Company's financial results for the quarter ended September 30, 2024, by incorporating a press release issued on the same date.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K document.
Material Changes
No specific material changes versus the prior comparable period are quantified in this filing text. The document directs readers to the referenced press release for the detailed results of operations and financial condition.
Guidance, Outlook, and Risks
The filing includes a standard Regulation FD disclosure regarding the press release. It explicitly states that the information furnished under Item 7.01 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of such section. Consequently, no specific guidance, outlook, or risk commentary is provided within the text of this 8-K itself.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 13, 2024) for actual Q3 2024 financial figures.
- Verify the Company's cash position and burn rate in the full press release, as this 8-K contains no liquidity data.
- Confirm any updates to clinical trial progress or regulatory milestones mentioned in the referenced press release.
- Check the Nasdaq Capital Market listing status for AEMD common stock.